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Biosynthetic phage display: a novel protein engineering tool
combining chemical and genetic diversity
Mary A Dwyer, Wuyuan Lu, John J Dwyer and Anthony A Kossiakoff
Background: Molecular diversity in nature is developed through a combination
of genetic and chemical elements. We have developed a method that permits
selective manipulation of both these elements in one protein engineering tool. It
combines the ability to introduce non-natural amino acids into a protein using
native chemical ligation with exhaustive targeted mutagenesis of the protein via
phage-display mutagenesis. 
Results: A fully functional biosynthetic version of the protease inhibitor eglin c
was constructed. The amino-terminal fragment (residues 8–40) was chemically
synthesized with a non-natural amino acid at position 25. The remaining
carboxy-terminal fragment was expressed as a 30-residue peptide extension of
gIIIp or gVIIIp on filamentous phage in a phage-display mutagenesis format.
Native chemical ligation was used to couple the two fragments and produced a
protein that refolded to its active form. To facilitate the packing of the
introduced non-natural amino acid, residues 52 and 54 in the carboxy-terminal
fragment were fully randomized by phage-display mutagenesis. Although the
majority of the observed solutions for residues 52 and 54 were hydrophobic —
complementing the stereochemistry of the introduced non-natural amino acid —
a significant number of residues (unexpected because of stereochemical and
charge criteria) were observed in these positions. 
Conclusions: Peptide synthesis and phage-display mutagenesis can be
combined to produce a very powerful protein engineering tool. The physical
properties of the environment surrounding the introduced non-natural residue can
be selected for by evaluating all possible combinations of amino acid types at a
targeted set of sites using phage-display mutagenesis.
Introduction
Structure and function in the natural protein world has
been primarily developed through evolution, based on
chemistries and structures using 20 left-handed amino
acids. One of the grand challenges in biology is to relate
how a pattern of 20 amino acids can be organized along a
polypeptide chain to give a uniquely functional form. A
very fruitful approach to investigate this principal issue
has been protein engineering coupled with structural
analysis, which has allowed functional elements to be sys-
tematically and thoroughly probed. With an increase of
the knowledge base, the scope of some of the studies has
expanded to include the creation of new functionalities
and the design of new structural entities based on existing
polypeptide scaffolds [1–4]. 
An important and powerful advance in protein engineer-
ing technology has been the development of phage-
display mutagenesis [5]. Phage display is an efficient
methodology used to produce and evaluate an extremely
large number of proteins with a selectable physical prop-
erty. Its underlying principle is that ‘trying all possibilities’
is a much more pragmatic and inclusive approach to devel-
oping optimized solutions than fully intellectual
approaches using site-directed mutagenesis. Using this
technique proteins with a number of novel and unex-
pected properties have been produced [6–12].
Although this method is very powerful in developing
diversity using the 20 amino acids, it still cannot duplicate
the versatility of nature. Nature has worked out systems to
greatly expand functional characteristics using post-trans-
lational modification and the incorporation of specialized
non-natural amino acids. Strategically placed, these chem-
ical moieties form the basis for many essential regulating
events, such as signaling and targeting functions
[10,13–15]. It follows that protein engineering could be
made even more powerful by expanding the genetic code
in a similar way; that is, including the ability to incorporate
non-natural amino acids with selected properties or the
capability to make post-translational modifications.
Efforts to introduce non-natural amino acids into a protein
sequence using in vitro translation methods have had
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some success, but are technically daunting [16,17]. There
is also considerable potential in using an intein–extein lig-
ation strategy [18]. Native chemical ligation, however, has
advanced rapidly as a technology for making large
polypeptides (up to 200 amino acids) [19–23], and its
success has been demonstrated through structural analysis
that has shown that the ligated fragments form a stereo-
chemically true peptide bond [24]. This technology has
the potential to greatly expand the repertoire of protein
function by strategic placement of highly functionalized
non-natural amino acids. 
Combining the versatility of synthetic proteins with the
power of targeted random mutagenesis and screening
using phage-display libraries offers extraordinary potential
to both the understanding and the rational design of
protein functionality. The question is how to do it? The
obvious drawback is a technical one: phage display is
genetics based and thus does not naturally partner with
synthetic approaches. To overcome this apparent incom-
patibility, we have adopted a straightforward approach. In
its simplest terms, it involves expressing a carboxy-termi-
nal fragment of the protein of interest on the phage and
coupling it to the chemically synthesized amino-terminal
fragment using the native chemical ligation technique.
The ‘full-length’ protein thus incorporates the polypep-
tide code to form a folded entity that contains synthetic
and genetically derived elements.
The segregation of the synthetic and genetic diversities
allows them to be manipulated separately; however,
having them separated in the amino- and carboxy-termi-
nal fragments, respectively, does not mean that the indi-
vidual diversities are necessarily separated in terms of
their influence on protein function. This situation reflects
the inherent feature of protein structure: spatial arrange-
ment of amino acid residues in a folded protein is gener-
ally independent of their position in the sequence. Thus,
systems can be designed such that in the folded form a
group introduced in the amino-terminal synthetic frag-
ment can lie adjacent to groups expressed in the phage-
originated peptide.
We report here the development and proof of concept of a
facile methodology to couple synthesized peptide frag-
ments to protein fragments expressed either monovalently
or polyvalently on filamentous phage. We have named this
method ‘biosynthetic phage display’, and discuss here two
applications that explore packing complementarity in a
folded protein. In these applications, non-natural amino
acids with very different stereochemical characteristics
were introduced into the hydrophobic core of eglin, a
70 amino acid residue serine protease inhibitor. The core
of the protein is made up of residues derived from both
the amino- and carboxy-terminal halves of the protein. In
each experiment, a synthetic fragment containing the first
33 amino acids was synthesized with a non-natural amino
acid at position 25, which is a phenylalanine residue in the
wild-type protein. The sidechain of Phe25 makes van der
Waals contacts with those of Val52 and Val54 [25–27].
Thus, although position 25 can be manipulated as part of
the synthesized amino-terminal peptide, eglin carboxy-
terminal fragments that include combinations for residues
52 and 54 are expressed as an extension on the amino ter-
minus of either the gIIIp or gVIIIp polypeptides of the
phage coat protein. Taken together these expressed frag-
ments include all of the 400 possible combinations
required for each of the amino acid types to be fully repre-
sented at positions 52 and 54.
The two non-natural amino acids introduced at position 25
were kynurenine (Kyn), an analog of tryptophan, and nor-
valine (Nva), a straight chain analog of valine. Kyn is note-
worthy in that it has fluorescent characteristics that are
very sensitive to dielectric environment, allowing us to
assess the local dielectric in the core of eglin [28,29].
Because it is significantly larger than phenylalanine, it was
assumed that adjustments of the packing environment,
specifically involving the sidechains of residues 52 and 54,
might be required to facilitate folding. Although common
wisdom would suggest that sidechains smaller than valine
would be required at these two positions to accommodate
Kyn, larger sidechains might be preferred to maximize
packing around the smaller and more flexible Nva.
The findings from the phage-display solutions for amino
acid sidechain types for positions 52 and 54 support some
of the above predictions; however, the variety of sizes and
types of amino acids that were found at positions 52 and
54, producing viable folded proteins, was unanticipated.
Consequently, we have developed a powerful technology
to couple synthetic and genetic diversity that has pro-
duced a rich source of proteins to study with a striking
broad set of packing characteristics.
Results
Validating chemical ligation to phage peptides — technical
considerations
Figure 1 outlines the method that has been developed
and tested for chemically ligating a carboxy-terminal
thioester-containing peptide to an amino-terminal cys-
teine-containing protein fragment, and expressed as a
fusion on the surface of a coat protein of filamentous
phage. The method involves a set of sequential steps.
Consequently, the efficiency of each step affects the
yields and ultimately the success of those steps that
follow. It was therefore critical to establish protocols that
maximized competent products at each step. 
Successful application of chemical ligation to a phage-
expressed peptide involves addressing several technical
issues. The first challenge was in the expression of the
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viable peptide fragment on the phage coat protein.
Expression of amino-terminal cysteine-containing pro-
teins in Escherichia coli is generally problematic [30]. As a
consequence, we expected the expression level on the fil-
amentous phage coat of this particular fusion product to
be lower than for typical peptides. Expression of viable
protein fragments can also be difficult because unfolded
polypeptides are more susceptible to proteolytic cleavage
and aggregation. In addition, we found that the presence
of 0.5% thiophenol and 6 M guanidinium HCl used for
the ligation reaction reduces the phage titer by ~tenfold
(data not shown). 
The ligation protocol is designed to couple exclusively
through amino-terminal cysteine sidechains, but as the
coat protein of the phage contains a large number of free
cysteines from the multiple copies of gVIIIp, it was impor-
tant to ascertain whether any competing reaction products
were being produced. A method to ligate a synthetic
peptide to an expressed protein using the intein–extein
approach has been reported [31]. To take advantage of the
expanded level of diversity of protein products available
from the phage-display approach, however, we needed to
perform this coupling on a phage substrate, which adds
another level of complexity. Described below are the
methodologies for the central steps of the procedure and
the sets of controls used to validate their success and
measure their efficiency.
Expression of the carboxyl-terminal eglin fragment on gIIIp
and gVIIIp proteins
Expression of the carboxy-terminal eglin peptide fragment
by both monovalent (gIIIp) and polyvalent (gVIIIp) phage
display was performed by displaying this peptide as a
fusion with the respective coat protein [32]. This carboxy-
terminal fragment contains residues 41–70 with a
Ser41→Cys mutation to provide the free amino-terminal
cysteine for the subsequent ligation. This fragment is
referred to as C-term. The expression levels of eglin
C-term–gIIIp and eglin C-term–gVIIIp fusion protein were
compared. Theoretically, a significantly higher expression
level would be achieved for a protein fragment–gVIIIp
fusion, as there are about 103 more copies of gVIIIp than of
gIIIp present on the phage coat [33].
Two types of phage-binding ELISA (enzyme-linked
immunoabsorbant assay) were used to quantify the
expression of eglin C-term–gIIIp and eglin C-term–
gVIIIp proteins (Figure 2). The first method used an
incorporated amino-terminal His6 tag as a means to
capture the recombinant phage with a Ni-nitrilotriacetic
acid (NTA) coated plate. Absorbance values (450 nm)
shown in Figure 2a illustrate a 450% (gVIIIp) and a 300%
(gIIIp) isopropylthiol galactosidase (IPTG) induction of
expression as compared with no IPTG treatment. A satu-
rating level of recombinant phage was applied to the
ELISA plate each with a titer of 1013 pfu/ml. Interestingly,
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Figure 1
Biosynthetic phage ligation. Steps 1 and 2:
the starting reagents are a carboxy-terminal
(amino acids 41–70) eglin peptide fragment
expressed as a fusion to either gVIIIp or gIIIp
(the amino-terminal residue is required to be
cysteine); and an amino-terminal synthetic
(amino acids 8–40) eglin peptide fragment
with a requisite carboxy-terminal thioester
(the red stripes designate altered groups,
and position 25 is the introduced non-natural
amino acid; 52 and 54 are residues mutated
in the phage libraries). Step 3: ligation
reaction catalyzed by thiophenol yielding a
full-length eglin (amino acids 8–70) fused to
either gVIIIp or gIIIp on the surface of the
filamentous phage. Step 4: the constructed
eglin molecule folds into an active
conformation. Positioning of the non-natural
amino acid at 25 and the mutated residues at
positions 52 and 54 are shown. Step 5: a
selection assay using a capturing agent is
performed to select for the folded eglin
ligation products. Step 6: captured phage
are propagated and the ligation reaction
followed by the selection assay are repeated
four times. Step 7: selected clones are
isolated and sequenced, identifying the
preferred eglin sequences selected from the
phage sorting.
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even though a higher level of expression was observed for
the gVIIIp fusion compared with the gIIIp fusion, this dif-
ference is not as significant as might be expected given
the greater number of potential fusion sites on gVIIIp
than on gIIIp.
The second phage-binding ELISA detects the presence
of the amino-terminal cysteine by capturing the recombi-
nant phage using a maleimide-coated plate. Figure 2b
illustrates roughly a 400% (gVIIIp and gIIIp constructs)
absorbance increase as compared with the phage not
expressing a fusion protein (VCS-M13). These absorbance
450 nm values represent the full, dynamic range for this
assay. These data confirm the presence of the amino-ter-
minal cysteine on the eglin C-term–gVIIIp and eglin
C-term–gIIIp fusion proteins.
Quantification of ligation products
As outlined in Figure 1, chemical ligation of the synthetic
eglin amino-terminal peptide to the phage-displayed eglin
C-term peptide was conducted, yielding fully active eglin
(8–70)–(gIIIp and gVIIIp) fusion proteins. The amino-ter-
minal peptide, referred to as N-term, was synthesized
with a carboxy-terminal thioester moiety. N-term had
wild-type sequence and consisted of residues 8–40. It had
previously been shown that the first eight residues are not
a structural requirement and their exclusion has no effect
on inhibitor potency [34]. Ligation products were
detected with a phage-binding ELISA using the high
affinity of eglin for Genenase ([35,36]; Kd = 0.14 nM), a
variant of the serine protease subtilisin BPN′, as a captur-
ing agent for properly folded eglin. As shown in Figure 3,
thiophenol-catalyzed ligations yielded 670% (gIIIp) and
680% (gVIIIp) absorbance (450 nm) increases as compared
with thiophenol-catalyzed ligations performed in the
absence of peptide. Uncatalyzed ligation reactions yielded
200% (gIIIp) and 300% (gVIIIp) absorbance (450 nm)
increases as compared with ligation reactions done without
peptide. Reactions performed in the absence of peptide
yielded an insignificant number of Genenase binders
(0.015 Å450 nm) compared with ELISA background mea-
surements (averaged 0.045 Å 450nm) that were subtracted
from each treatment. These findings also indicate that,
although ligation occurs without addition of thiophenol,
this catalyst increases the formation of the product by
about threefold. Noncovalent association of the eglin
N-term and C-term fusion halves is highly unlikely
because the sorting wash steps would most likely disrupt
any such interactions.
Application to producing viable biosynthetic phage display
libraries
The above studies demonstrated that the individual steps
to ligate a carboxy-terminal thioester-containing peptide
selectively to an amino-terminal cysteine-containing
protein fragment of phage could be efficiently achieved. It
was not clear, however, when these steps are linked
together, whether enough competent biosynthetic phage
could be produced to accommodate effective phage selec-
tions. To address this issue, we conducted four rounds of
ligation of synthetic eglin N-term to eglin C-term–gVIIIp
followed by Genenase-binding selection and phage propa-
gation. Following each round of ligation/binding selection,
the phage titer was ~1013 pfu/ml as determined using stan-
dard methods [33]. This finding indicates that ample
phage titers are recovered to perform numerous rounds of
ligation–binding selection. 
To apply the ligation method in the context of the phage-
display libraries, two different synthesized eglin N-term
peptides were chemically ligated to separate polyvalent
phage-display libraries of eglin C-term. These polyvalent
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Figure 2
Evaluation of eglin C-term–gIIIp and eglin
C-term–gVIIIp protein expression with two
types of phage-binding ELISAs (average of
three ELISAs). (a) Absorbance (450 nm)
values from a phage-binding ELISA using the
incorporated His6 tag as a means to capture
the recombinant phage. IPTG induction of
expression is shown by comparing +IPTG
(10 µM) and –IPTG treatments.
(b) Absorbance (450 nm) values from a
phage-binding ELISA using the incorporated
amino-terminal cysteine residue as a capturing
agent for the recombinant phage. Both
ELISAs used an anti-VCS-M13-horseradish
peroxidase (HRP) conjugated antibody as a
means of detection and used a saturating
level of recombinant phage each with a titer of
1013 pfu/ml.
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C-term libraries were designed to mutate simultaneously
at positions Val52 and Val54. The two synthetically pro-
duced amino-terminal peptides contained different non-
natural amino acid at position 25. (In the folded native
protein, position 25 contains a phenylalaine residue that is
buried in the hydrophobic core and packs against Val52
and Val54.) One of the non-natural amino acids was Kyn
(N-term (Kyn)), which is a fluorescent analog of trypto-
phan, and the other was Nva (N-term (Nva)), a straight-
chain analog of valine. 
Variants of eglin C-term at positions Val52 and Val54 were
generated by constructing two phagemid libraries. The first
library (NNS) was designed to contain codons for all
20 amino acids at positions 52 and 54 (Table 1). This
process is referred to as ‘hard’ randomization. The second
library (VRS) was constructed to restrict the residues in
these two positrons to histidine, glutamine, asparagine,
lysine, aspartate, glutamate, arginine, serine or glycine, thus
choosing these residues to be polar. The first library there-
fore contains all the potential solutions for substitutions at
52 and 54 to accommodate the larger Kyn and the flexible
Nva. The polar-biased library is much more restricted, with
glycine being the ‘rescue’ residue if no combination of
polar residues is possible at these positions (Table 1).
Ligation to the phage fragment
Following construction and propagation, the expressed
eglin C-term protein fragments produced in both these
phage libraries were chemically ligated to the N-term
(Kyn) and N-term (Nva), yielding two sets of binding-
competent eglin variants. The ligation products from the
hard-randomized (NNS) and polar-biased (VRS) libraries
were detected using the Genenase-coated phage-binding
ELISA described above (Figure 4). The N-term (Nva)
selections did not include the VRS library. The eglin
Val52 and Val54 variants from both NNS and VRS
libraries showed a ~sixfold absorbance (450 nm) increase
relative to ligations performed in the absence of peptide. 
Screening involved four rounds of ligation followed by
Genenase-binding selection were carried out for these eglin
(with Phe25→Kyn and with Phe25→Nva) polyvalent phage
libraries (as described in the Materials and methods
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Figure 3
Detection of full-length eglin–(gVIIIp and gIIIp) chemical ligation
products with a phage-binding ELISA using the high affinity of eglin for
Genenase (Kd = 0.14 nM) to select for properly folded eglin.
Thiophenol catalysis (final concentration = 0.5%) of the ligation
reaction is indicated by comparison of the absorbance 450 nm values
(average of three ELISAs) for the following treatments: thiophenol
added (+TP); no thiophenol added (–TP); no peptide added (–P).
Background absorbance 450 nm readings (0.045 A 450 nm) were
subtracted for each treatment in Figures 3 and 4.
Table 1
Codons and relevant statistical information for choosing amino acids to be a specific type.
Name Codon* Amino acid No. codons Total† Library size needed‡ Max no. residues§
Polar VRS H,Q,N,K,D,E,R,S,G 12 4(12)8 2 × 109 8
Nonpolar NYS K,L,S,P,M,I,T,V,A 16 4(16)7 1 × 109 7
Nonaromatic VYS L,P,M,I,T,V,A 12 4(12)8 2 × 109 8
Aromatic TNS F,L,S,Y,stp,C,W 8 4(8)9 5 × 108 9
Hard randomization NNS All 32 4(32) 5 1 × 109 5
Characteristics of phage libraries choosing polar, nonpolar, aromatic,
nonaromatic and nonbasic residues. For each type of biased residue,
the represented codon, amino acids (using single-letter code) and
number of codons are listed in the above table. stp. stop codon (TAG).
*The nomenclature for these codons is as follows: N = G + A + T + C;
V = A + C + G; Y = C + T; R = A + G; S = C + G. Codon base
wobbles are synthesized using deoxynucleotide mixtures as follows:
four way, 25% each; three way, 33% each; two way, 50% each. †For
each biased library type, the maximum number of randomized residues
is determined based on statistical calculations for total representation
(4(number codons)n), where n is number of randomized residues [33]
and current electroporation limits (1 × 1010 independent
transformants/library). ‡Transformants required for total representation
of biased libraries. §Maximum number of residues that can be
simultaneously mutated preserving total representation.
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section). After the fourth round of ligation/selection, enrich-
ment of the eglin (with Phe25→Kyn) phage libraries was
~tenfold for the hard-randomized library (NNS) and 15-fold
for the polar-biased library (VRS) compared with the back-
ground binding to a phosphate buffered saline (PBS)-coated
control well. Similarly, four rounds of ligation/selection of
the eglin (Phe25→Nva) phage libraries yielded an eightfold
enrichment for the hard-randomized library (NNS) and 14-
fold enrichment for the polar-biased library (VRS) as com-
pared with background binding to a PBS-coated well.
Kynurenine at position 25
Table 2 contains the resulting amino acids obtained from
the hard randomization (NNS) of positions 52 and 54 with
Kyn at position 25. The phage-derived clones were isolated
following four rounds of selection. The composite of the 27
sequenced clones of Phe25→Kyn showed a well-defined
pattern at both positions 52 and 54. On the basis of codon
usage, the hard-randomized library indicated a preference
for either glycine, with a standard deviation (σn) of 3.4 σn
for amino acid 52 and 3.3 σn for amino acid 54 or valine,
9.9 σn for amino acid 52 and 7.7 σn for amino acid 54
(Table 3). The σn and the significance scores were calcu-
lated as shown in Table 3. Only residues for which σn was
greater than 1 were considered significant. Also notewor-
thy, clones were isolated that had a wide variety of amino
acid types at these positions. These involved, among
others, residues with large sidechains such as tryptophan, as
well as those with both basic and acidic moieties. Although
it would be expected that proteins with large or charged
sidechain types at either position mutated would be less
stable than those with more complementary groups, this
latter category still represents a group of viable proteins.
In the polar-biased libraries, both positions showed a pref-
erence for glycine [3.1 σn (amino acid 52); 4.75 σn (amino
acid 54)] (Table 3). In 6 of the 19 sequences, residues 52
and 54 were both glycines. In eight other sequences,
glycine was found at one of the positions. The polar
residues found at one or the other position had a fairly
broad spectrum of stereochemical traits. Only serine was
not represented among the possible sidechain types con-
tained in the polar library. The extent of the variability is
characterized by having sequences that were fully acidic,
Glu:Glu; fully basic, Lys:Arg; or a mix, Lys:Asp.
Norvaline at position 25
Eglin (Phe25→Nva) library phage clones were isolated
following four rounds of selection followed by DNA 
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Figure 4
Chemical ligation to produce phage libraries consisting of eglin (amino
acids 8–70)–gVIIIp variants containing the non-natural amino acid Kyn
at position 25. Absorbance values (450 nm) from a phage-binding
ELISA (described in Figure 3) performed following the final (fourth)
round of phage library sorting are shown. Eglin C-term–gVIIIp served
as the positive control for the ligation reaction (data not shown) and
ligation in the absence of peptide was the negative control. 
Table 2
Amino acids for eglin residues 52 and 54 after sorting eglin
(F25Kyn)–gVIIIp and eglin (F25Nva)–gVIIIp phagemid libraries.
Kyn at position 25 Nva at position 25
NNS VRS NNS
Freq. 52 54 Freq. 52 54 Freq. 52 54
G V 6 G G K L
G E K D 3 A V
G A 2 D G 3 L V
V C E E I L
4 V V G N P L
K H G K 2 N V
2 V G N K 2 T V
L G G E V T
V E E G 2 P V
2 L V Q G 4 V L
G D H G 3 V V
K V N G 2 V A
M F K R 2 I V
G Y 2 L D
V L 2 L A
W G I A
V D V C
P C D A
R W 2 T L
R G V I
E R 2 N L
G G 2 L I
D V
T A
3 A L
Frequency indicates the number of times the pattern of sequence
was found.
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isolation and sequencing. The sequence analysis of the
46 clones indicated a different preferred sequence for
the two positions (Table 2). Position 54 showed a defi-
nite preference for valine (13.8 σn) and other nonaro-
matic hydrophobic residues (Leu, 4.8 σn; Ala, 2.5 σn; Ile,
1.2 σn). Position 52 showed a more variable set of
sequences (Leu, 2.4 σn; Ala, 1.9 σn; Ile, 2.2 σn; Asn,
2.2 σn; Tyr, 1.3 σn), but retained a strong preference for
the wild-type valine (8.8 σn). 
Protein diversity versus DNA diversity
In the hard randomization of residues 52 and 54 of the
Phe25→Nva mutant, several sets of identical solutions
were isolated (Table 2). At issue was whether these repre-
sented true independent solutions or whether their
repeated presence was a function of stability or expression
factors. Table 4 shows the codon usage for three sets of
these solutions: valine, leucine (frequency [n] = 4);
alanine, leucine (n = 3); alanine, valine (n = 3). The DNA
sequence data indicate that each of the solutions in the set
are independent at the DNA level. Thus, it is apparent
that the phage selection is a robust process that uses a
diverse set of DNA sequences to derive a more narrow set
of protein solutions.
Discussion
The coupling of synthetic chemistry to phage-display
mutagenesis significantly expands the capabilities to build
new functionality into proteins by combining chemical
and genetic diversity into a single method. It has long
been recognized that non-natural amino acids, if they
could be substituted at specific sites in a protein, could
alter protein function in quite unique and important ways.
The question has centered on how to incorporate them. 
The challenge of introducing non-natural amino acids into
a protein sequence has been approached in several differ-
ent ways. The more traditional methods involve chemical
modification of existing amino acids [37] or in vitro transla-
tion using misacylated tRNAs [16,17]. However, using the
first approach has inherent difficulties in achieving speci-
ficity and the latter approach often fails to produce a rea-
sonable amount of product. In an alternative approach,
synthetic peptides containing non-natural amino acids
have been ligated to protein fragments by enzymatic
means using a peptide ligase [38]. Many other approaches
have been used for enzymatic semisynthesis [39];
however, each of these techniques have limitations related
to enzymatic specificity, solvent constraints or solubility
issues. Recently, native chemical ligation has emerged as a
general method to synthesize full-length proteins and
allows specific incorporation of a wide variety of non-
natural amino acids [19]. This approach has been
extended to allow ligation of synthesized peptides with
expressed protein fragments using an intein–extein strat-
egy (recently reviewed [40]).
As potentially powerful as the native ligation method is,
it has one important drawback. Unless the introduced
non-natural amino acid is isosteric with the one it
replaces, forming a stable protein might require addi-
tional changes in the protein core to reoptimize the
packing environment of the introduced group. For
instance, we describe here a study where a large fluores-
cent reporter group is introduced into the hydrophobic
core of eglin. It replaces a somewhat smaller group sug-
gesting that the additional volume has to be accommo-
dated by a set of packing adjustments. 
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Table 3
Consensus residues identified after sorting eglin
(Phe25→Kyn)–gVIIIp phagemid libraries.
Position Residue Pe σn Pf Pf–Pe/σn
NNS library
Val52 G 0.062 0.046 0.259 3.4
V 0.031 0.033 0.370 9.9
K 0.031 0.033 0.074 1.2
Val54 G 0.062 0.046 0.222 3.3
V 0.031 0.033 0.296 7.7
D 0.031 0.033 0.074 1.2
E 0.031 0.033 0.074 1.2
C 0.031 0.033 0.074 1.2
Y 0.031 0.033 0.074 1.2
VRS Library
Val52 G 0.167 0.080 0.409 3.1
Val54 G 0.083 0.059 0.545 4.8
The most frequently occurring residues from the NNS and VRS phage
libraries are shown, based on fractional representation (Pf) among all
clones isolated after four rounds of binding selection. Expected
frequencies (Pe) were calculated from the number of VRS and NNS
codons for each amino acid theoretically in the starting library. Standard
deviations (σn) were calculated as σn = [Pe(1–Pe)/n]1/2 and termed a
‘significance score’. Only residues for which the fraction found
exceeded the fraction expected by at least 1σn (i.e. [(Pf–Pe)/σn] > 2) are
shown. For the NNS library, n = 27 sequences; for the VRS library,
n = 22 sequences.
Table 4
Comparison of position 52 and 54 eglin library amino acid and
DNA sequences.
Position 52 Position 54
Pair at 52,54 Amino acid CODON Amino acid CODON
V, L V GTC L CTC
V GTG L CTG
V GTC L TTG
A, L A GCC L CTG
A GCG L CTC
A GCC L CTC
A, V A GCC V GTG
A GCG V GTG
A GCC V GTC
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Although rational design solutions to such problems are
intellectually pleasing, lessons learned from many protein
engineering studies suggest that genetic approaches are
often better providers of the optimum solutions. It is at
this interface, between introducing a nonisoteric amino
acid into a folded protein and being able to accommodate
it, that the biosynthetic phage-display approach is very
powerful. We have shown that the method will select
those solutions that are most highly preferred, as well as
indicating the range of amino acid types that can produce
viable protein products.
Introduction of Kyn at position 25 of eglin
Kyn is a derivative of tryptophan that can be used as a fluo-
rescent reporter group for assessing local dielectric environ-
ments [28,29]. Our objective was to introduce Kyn into the
interior of eglin thereby enabling us to obtain direct exper-
imental data relating to apparent dielectric values within
the protein core. Such information has been elusive and
represents a critical step in improving modeling of electro-
static effects in protein interiors and active sites [41,42]. 
Previous attempts to introduce Kyn and other similar
reporter groups into protein systems have relied on chem-
ical modification or passive diffusion approaches [37].
Each of these methods suffers from specificity and effi-
ciency issues. Using native chemical ligation, the eglin
molecule can be readily synthesized [24]. As Kyn can be
purchased in amino acid form, there are no technical
issues with inserting Kyn in place of phenylalanine at
position 25. However, Kyn is significantly larger (~ 60 Å3)
than phenylalanine and has a polar component, which
together could perturb folding and stability of the
protein. In an attempt to circumvent these problems and
to ascertain the nature of possible environments around
the Kyn sidechain, we used the phage display arm of the
method to screen for compensating packing mutations.
We note that this method samples all possibilities
because the size of the library produces up to 109 protein
sequences, and thus is highly over-determined to produce
all 400 combinations possible in the simultaneous ran-
domization of two positions.
Screening phage-display-derived clones of eglin (Phe25→
Kyn) for binding to Genenase yielded a strong preference
for nonpolar groups at positions 52 and 54. Only about
30% of the solutions had a polar group at either position 52
or 54. Based on expected probabilities, the presence of
glycine and valine is disproportionally high. Although the
occurrence of these small nonpolar amino acids might be
predicted, the presence of other solutions with larger
amino acids was unexpected. 
In the polar-biased library, six of the 19 sequenced clones
had Gly52–Gly54 solutions. Nine clones had Gly52–X54
or visa versa and only four clones were found with polar
residues at both positions. These results suggest that the
rescue solution, Gly–Gly, predominates in the selections.
In modeling studies of the eglin (Phe25→Kyn), Gly and
Val could be accommodated at positions 52 and 54.
Figure 5 pictures the stereochemical relationships
between a putative Kyn25 orientation and two different
solutions for observed 52 and 54 sidechain types. These
solutions were picked to be modeled because the combi-
nation of residue types found were not expected based on
size and charge criteria. The model of Phe25→Kyn,
Val52→Arg and Val54→Trp shows that the Kyn can stack
perpendicular to the Trp54 sidechain with the arginine
sidechain rotated such that some of it aliphatic carbons are
packed against the tryptophan sidechain. In the modeled
orientation, the guanidinium moiety has exposure at the
surface. In the Val52–Val54→Glu mutant, the Kyn
sidechain can be flipped (data not shown) to accommodate
the energetically most favorable conformations of the 52
and 54 sidechains, while additionally forming an hydrogen
bond between the carboxylate oxygen of Val52→Glu and
the phenolic nitrogen of Kyn (~3.2 Å). We note that the
accuracy of these assignments will have to be verified
through a direct structural analysis. 
Norvaline at position 25
Substitution of phenylalanine for Nva at position 25 may
result in the formation of a cavity, because the volume of
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Figure 5
Structure of eglin c. The green chain is the synthesized fragment 8–40
with Kyn at position 25. The yellow chain is an expressed phage
fragment (41–70) with altered groups at 52 and 54. Proposed packing
fit is shown with Kyn at residue 25 and arginine or valine at position 52
and tryptophan or aspartate at position 54. 
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this residue is ~50 Å3 less than phenylalanine. After the
phage sorting, hydrophobic residues were observed for
position 54, but a broader distribution of residue types
were observed for position 52. Of the 46 clones
sequenced, 31 had hydrophobic groups at both positions.
(valine or leucine appeared 21 times at position 52 and 32
times at position 54.) The remaining 14 clones had some
combination of a nonpolar, polar mix. Note, however, that
in 12 of these cases, it was position 52 that accommodated
the polar sidechain. This suggests that the environment
surrounding it is somewhat more amenable to polar groups
than that around residue 54.
Figure 6a is a histogram showing the distribution of the
summed volumes of the 52 and 54 sidechains with a Nva
at position 25. Generally, there is a symmetric distribu-
tion around the volumes of two valine residues
(2 × 75 Å3 = 150 Å3), which are the wild-type residue
types. There are clearly viable proteins made that have
significantly larger volume displacements, for instance
Lys52–Leu54 (206 Å3) or Leu52–Ile54 (204 Å3). Although
these occurrences are somewhat rare, modeling suggests
that these can be accommodated with modest adjust-
ments of surrounding groups. The distribution of size
between positions 52 and 54 indicates a slight skewing
towards the sidechain 54 being larger than the 52
sidechain (Figure 6b,c).
Significance
Protein engineering is powerful approach to developing a
better understanding of the fundamental rules linking a
protein’s structure to its function. Two recently devel-
oped methodologies promise to make significant contri-
butions. In the first technique, total chemical synthesis of
proteins, using native chemical ligation, facilitates the
introduction of non-natural amino acids and alteration of
peptide bond stereochemistries. This synthetic access to
chemical derivatives greatly expands the potential reper-
toire of function. The second technique, phage-display
mutagenesis, is extraordinarily efficient in producing and
evaluating an extremely large number of possible solu-
tions with a desired physical property. It has been coined
‘evolution in a test tube’ because the library sizes allow
up to 109 protein sequences to be evaluated in a single
experiment. 
Biosynthetic phage display synergizes the integration of
synthetic chemistry and genetic diversity, providing a
unique method to build new and uniquely functional
attributes into proteins. We believe that application of
this method to engineer protein cores, active sites and
macromolecular interfaces will contribute greatly to our
ability to both understand and rationally manipulate the
physicochemical properties that drive protein function.
Non-natural amino acids with a functional group can be
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Figure 6
A histogram plotting the frequency of occurrence versus the range of
volumes for eglin (Phe25→Nva) positions 52 and 54. (a) The volume
distribution for both positions 52 and 54 indicates a symmetric
distribution around the volumes of the two wild-type residues.
Comparison of the volume distributions for (b) position 52 and
(c) position 54 suggests a slight skewing toward sidechain 54 being
larger than 52.
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introduced via the chemical synthesis arm of the
method, whereas the local packing environment of the
incorporated group can be optimized for a desired trait
by altering the steric and electrostatic features of neigh-
boring residues using phage-display mutagenesis.
An important aspect of the biosynthetic phage display
method is that it not only identifies the optimal solution,
but it can also generate a broad spectrum of unexpected
but viable solutions. This latter category provides a rich
source for the biophysical analysis of proteins that have
undergone structural compromise to accommodate non-
ideal packing features. For instance, for the introduction
of the fluorescent reporter group, kynurenine (Kyn), the
resulting sequences based on phage-display mutagenesis
suggested that the most preferred solutions contained
small hydrophobic amino acids at positions 52 and 54.
However, solutions with tryptophan or charged
sidechains in these positions were also found. This was
unexpected based on the stereochemistry of Kyn. Addi-
tionally, phage-display libraries were constructed to
express a subset of residue types based on a particular
stereochemistry or hydrophobicity. For example, only
hydrophobic or charged amino acids would be allowed
for determining a given packing solution. In the study
presented here, phage-display libraries were created that
required residues 52 and 54 to be polar or glycine.
Although a significant fraction of the solutions involved
selection of glycine, a number of combinations of
charged sidechains also made viable proteins. These are
obviously the ones that will be interesting to analyze
further structurally and biophysically.
Materials and methods
Construction of gVIIIp and gIII phagemid vectors with eglin
(nucleotides 120–210)
Standard recombinant DNA techniques were used to construct recom-
binant phagemid transfer vectors based on the vectors ps657(gVIIIp)
and ps657(gIIIp) (provided by S. Sidhu, Genentech). The M13 gIIIp
display vector ps657(gIIIp) was constructed by replacing the
EcoRI/Nsi I fragment of pH0753 (a monovalent human growth hormone
(hGH) display vector [33]) with a PCR amplified 1.6 kb fragment from
pMalp2 (New England Biolabs). Beginning at nucleotide 1 for both the
pMalp2 and ps657(gIIIp) vectors, this fragment contained the lacIq
gene and a gene fragment encoding the signal peptide from the
maltose-binding protein under control of the isopropylthiogalactoside
(IPTG)-inducible Ptac promoter. As a result, production of the eglin
C-term fusion protein was both IPTG-inducible and tightly regulated in
the absence of IPTG by the lacIq gene. 
The hGH gene was then removed and replaced by a glycine/serine
linker (SGGGSGSG). The M13 gVIIIp display vector ps657(gVIIIp)
was analogous to ps657(gIIIp) except that gIIIp was replaced by gVIIIp
and the glycine/serine linker (GGGSGSSS) was slightly different. Both
vectors contained linker regions with unique Nsi I and XbaI sites which
allowed directional in-frame cloning of the eglin gene fragment using
Nsi I (at the 5′ end) and XbaI (at the 3′ end). Specifically, both the
ps657(gVIIIp and gIIIp) vectors were linearized with Nsi I and XbaI and
treated with shrimp alkaline phosphatase (Promega). The carboxy-ter-
minal portion of eglin (nucleotides 120–210) was PCR amplified to
introduce two modifications: first, the first 5′-end codon (nucleotides
120–123) was mutated from serine to cysteine; secondly, a His6 tag
coding sequence was introduced adjacent to the 3′-end of the eglin
sequence. The template for the polymerase chain reaction (PCR)
amplification was the vector, pET27b (Novagen) with the eglin gene
inserted at NdeI (5′) and BamHI (3′) sites (provided by T. Komiyama at
the University of Michigan). 
The following oligonucleotides: forward, 5′-PAGCATCATGCATTGT-
CCTGTTACCCTG-3′ Nsi I site in bold; reverse, 5′-PAGCATC-TCT-
AGAGTGATGGTGATGGTGATGACCAACATGCGG-3′ (XbaI site in
bold, His6 tag in italics and the eglin sequence is bold and italicized)
were used as primers. The linearized vectors were then ligated with
the eglin (nucleotides 120–210)/ His6 tag cDNA insert. Following lig-
ation, competent E. coli XL1-Blue were transformed, and bacteria
were selected for the correct recombinant plasmids (termed
ps657(gVIIIp)–eglin (nucleotides 120–210) and ps657(gIIIp)–eglin
(nucleotides 120–210) by DNA sequence analysis using the dRho-
damine dye-terminator method and an Applied Biosystems ABI Model
377 automated DNA sequencer. This construct yielded a fusion
protein that consisted of a secretion signal, eglin C-term peptide, a
His6 tag, a glycine/serine linker and either protein gIIIp or protein
gVIIIp. An amber stop (TAG) codon was present between the eglin
(nucleotides 120–210)/ His6 tag protein and the linker region (within
the XbaI cut site). An amber suppression E. coli strain was therefore
used for phage display (e.g. XL1-Blue).
Phagemid particles displaying the eglin C-term fragment (either monova-
lently or polyvalently) were prepared using the following method. ps657
(gIIIp and gVIIIp)–eglin (nucleotides 120–210) constructs were trans-
formed into E. coli XL1-Blue cells (Stratagene). Then, mid-log cultures
(250 ml 2 × YT with 50 µg/ml ampicillin and 10 µM IPTG, in a 2 l
beveled flask at 225 rpm, 37°C) were infected with VCS-M13 helper
phage (Stratagene) at a multiplicity of infection equal to three. Infected
cultures were grown for 16–18 h and resultant phagemid particles were
purified by two polyethyleneglycol (PEG; MW = 8000, 20% with 2.5 M
sodium chloride) precipitations from 250 ml of clarified culture super-
natants. Phagemid particles were resuspended in peptide ligation buffer
(0.2 N potassium phosphate pH 7.5/6 M guanidine hydrochloride)
Phage titers were determined by infecting tenfold serial dilutions with
mid-log phase E. coli XL1-Blue and observing resultant plaques. Typical
phage titers ranged from 1 × 1014 to 1 × 1015 plaque forming units/ml.
Peptide synthesis
Experimental details for the total synthesis of eglin C-term by native chem-
ical ligation have been described by Lu et al. [24]. For this study, the two
thioester peptides, (8–40)Kyn25–SR and (8–40)Nva25–SR, were syn-
thesized in stepwise fashion on custom-made thioester-generating resin
[21] using the published in situ neutralization/HBTU activation protocol
for Boc chemistry solid-phase peptide synthesis [43]. The following
sidechain protection was used: arginine(Tosyl); asparagine(Xanthyl);
aspartate(OcHxl); glutamine(OcHxl); histidine(Bom); lysine(2ClZ);
serine(Bzl); threonine(Bzl); tyrosine(BrZ). After HF deprotection and
cleavage from the resin, the crude peptides were purified by preparative
reversed phase high-performance liquid chromatography. Molecular
weights of the peptides were verified by electrospray ionization mass
spectrometry (data not shown).
Phage-binding ELISA for detection of eglin C-term–gVIIIp and
eglin C-term–gIIIp fusion proteins
Eglin C-term–gIIIp and eglin C-term–gVIIIp recombinant phage expres-
sion was evaluated by ELISA using the incorporated His6 tag as a means
to capture the fusion phage–proteins. Thus, eight fivefold serial dilutions
of the phage (100 µl/well; phage resuspended and diluted in Buffer #1
(PBS with 0.2% bovine serum albumin (BSA; Calbiochem) and 0.1%
Tween 20) were applied to Ni-NTA Hisorb 96-well microtiter plates
(Qiagen; 1.5 h, room temperature, moderate agitation). Non-induced
phage and no application of detecting antibody served as negative con-
trols. The plates were washed 3× with 400 µl/well of Buffer #1 and
blotted dry. Anti-VCS-M13-horse-radish peroxidase (HRP; Pharmacia)
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conjugated antibody was diluted 1:5000 in Buffer #1 and 100 µl/well
was applied (1 h, room temperature, moderate agitation). The wash step
was then repeated as described. Colour was developed by adding
100 µl/well of 1-step Turbo 3, 3′, 5, 5′-tetramethylbenzidine (TMB) sub-
strate (Pierce) for 5–10 min and stopped by adding 100 µl/well 4.5 N
sulfuric acid. The absorbance 450 nm (A450 nm) was measured and
plotted in histograms as shown (Figures 2–4).
Amino-terminal cysteine determination ELISA
The presence of the eglin C-term (gVIIIp and gIIIp) amino-terminal cys-
teine residue was detected by a phage-binding ELISA, using a
maleimide-coated plate (Pierce; 100 µl/well; phage resuspended in
Buffer #1 for 1.5 h at room temperature with moderate agitation). This
maleimide-coated plate covalently captured recombinant phage
expressing the amino-terminal cysteine. Phage expressing gVIIIp
without a fusion protein were included as a negative control. All subse-
quent washing and detection steps were performed as described in
the phage-binding ELISA section.
Chemical ligation of eglin N-term to eglin C-term/gIIIp and
eglin C-term/gVIIIp
Figure 1 depicts the chemical ligation process. Specifically, the ligation
was conducted using recombinant phage resuspended in 1 ml reaction
buffer (0.2 N potassium phosphate, pH 7.5 with 6 M guanidinium
hydrochloride). The concentration of recombinant phage fusion proteins
was estimated to be 0.2 nM, assuming a titer of 1013 pfu/ml with a viable
fusion protein expression rate of 1%. The eglin (N-term) peptide with a
thioester at the carboxyl terminus was resuspended in the reaction buffer
at a final concentration of 100 µM, yielding a large ratio of peptide to
recombinant phage fusion protein. Thiophenol (0.5% final concentration)
was added to catalyze the ligation reaction performed at room tempera-
ture with gentle rotary mixing for 24 h. Addition of 10 mM (final concen-
tration) dithiothreitol quenched the reaction. Then, eglin (gVIIIp and gIIIp)
ligation products were detected using the phage-binding ELISA
described below. Two controls were included for each treatment. As the
ligation reaction will proceed at a slower rate in the absence of thiophe-
nol, a reaction omitting thiophenol was included to show thiophenol
catalysis of the reaction. In addition, a reaction without addition of
peptide was included for each treatment as a negative control.
Phage-binding ELISA detection of eglin (gVIIIp and gIIIp)
ligation products
Eglin has a high affinity for Genenase (Kd = 0.14 nM [36]) allowing this
protease to be used as a selection agent for properly folded eglin fol-
lowing the ligation reaction described above. Genenase is a subtilisin
variant generated by mutating the catalytic histidine (His64) to alanine
[35]. Although this enzyme is inactive, it still retains its strong binding
capacity for most substrates and inhibitors. 
Maxisorb 96-well plates (Nunc) were coated with Genenase (10 µg/ml
in 50 mM Carbonate buffer, pH 9.6; 100 µl/well, o/n, 4°C). After
washing the plates as described above, the plates were blocked with
5% BSA, 0.01% Tween-20 in PBS (200 µl/well, 2 h, room temperature
with moderate agitation). After further plate washing, the phage from the
ligation reaction were applied to the blocked, Genenase-coated plate
(100 µl/well, 2 h, room temperature with moderate agitation). All subse-
quent wash and detection steps were performed as described above.
Construction of eglin C-term–gVIIIp phagemid libraries
Two eglin C-term–gVIIIp-phagemid libraries were constructed varying
the residues at positions Val52 and Val54. The hard-randomized library
(NNS) randomly mutated Val52 and Val54 using the following phos-
phorylated oligonucleotide: 5′-TAC AAC CGT NNS CGC NNS TTC
TAC AAC-3′, where N represents any of the four nucleotides and S
represents either a G or a C. The polar-biased library (VRS) allowed
Val52 and Val54 to be histidine, glutamine, asparagine, lysine, aspar-
tate, glutamate, arginine, serine or glycine, using the following phos-
phorylated oligonucleotide: 5′-TAC AAC CGT VRS CGC VRS TTC
TAC AAC-3′, where V represents a C, A, or G; R represents either an
A or a G; and S represents a G or a C (J.J.D., unpublished observa-
tions). Oligonucleotide-directed mutagenesis was used to construct
these libraries using ps657(gVIIIp)–eglin (nucleotides 120–210) as a
template. The library mutagenesis products were electrotransformed
into E. coli XL1-Blue (Stratagene) cells for phagemid preparation yield-
ing 1 × 109 independent transformants as described previously [44].
Sorting of NNS and VRS (positions V52, V54) eglin(C-term)–
phagemid libraries: 
Four rounds of ligation followed by binding selection using Genenase
were performed for these libraries. First, propagated phage generated
from each library was chemically ligated to the eglin peptide. Then, liga-
tion products corresponding to eglin with either Kyn or Nva at position
25 were selected on the basis of their ability to properly fold and bind
to Genenase. Specifically, Genenase was coated onto 96-well Max-
isorb plates (Nunc) (10 µg/ml in 50 mM Carbonate buffer, pH 9.6;
100 µl/well, overnight, 4°C) and blocked as described above. Both
libraries were sorted by adding ~1 × 1013 phage particles to the Gene-
nase-coated wells as well as duplicate PBS mock coated wells for a
negative control. All wells were washed 10 × as described above.
Phage particles were eluted with 0.2 M glycine, pH 2.0, neutralized
with 1 M Tris base. The phage were titered and propagated as previ-
ously described. Following propagation, phage from each library were
harvested (PEG precipitated similar to described above) and chemi-
cally ligated to the eglin peptide to begin a second round of selection.
Following four rounds of sorting, DNA from individual clones was iso-
lated and sequenced (described above).
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